ARTICLE | Clinical News
Remicade infliximab regulatory update
June 2, 2008 7:00 AM UTC
U.K.’s NICE issued a final appraisal recommending against the use of Remicade infliximab to treat severe ankylosing spondylitis. The agency concluded that the agent is not cost effective for the indic...